Drug intelligence / Profile preview

Gangju Qingyan

Development stage: Unknown
Lead developer: Gushengtang
Modality: Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

Gangju Qingyan is a traditional Chinese medicinal formulation available in granule form, purportedly developed for anti-inflammatory applications and respiratory health. It is positioned as an herbal medicine targeting airway inflammation in contexts such as haze or pollution exposure, although detailed proprietary composition, mechanism, and full clinical profile are not publicly detailed.

Brand names: Gangju Qingyan
Other names: Gangju Qingyan Granules

Beyond the preview

Go deeper on Gangju Qingyan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gangju Qingyan.

Explore the full profile